PP
TARO

PDT Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

PDT Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,905
Closed -$281K – 945
2021
Q2 		$281K Buy
3,905
+628
+19% +$46.1K 0.02% 625
2021
Q1 		$242K Buy
+3,277
New +$249K 0.02% 660
2020
Q4 		– Sell
-4,800
Closed -$263K – 882
2020
Q3 		$263K Sell
4,800
-1,300
-21% -$80.9K 0.02% 570
2020
Q2 		$406K Sell
6,100
-2,000
-25% -$134K 0.03% 463
2020
Q1 		$496K Hold
8,100
– – 0.04% 373
2019
Q4 		$712K Buy
+8,100
New +$683K 0.04% 345
2015
Q3 		– Sell
-18,512
Closed -$2.66M – 1629
2015
Q2 		$2.66M Buy
18,512
+772
+4% +$110K 0.07% 336
2015
Q1 		$2.5M Buy
17,740
+11,240
+173% +$1.73M 0.06% 388
2014
Q4 		$963K Buy
6,500
+1,200
+23% +$176K 0.09% 308
2014
Q3 		$815K Buy
5,300
+1,000
+23% +$151K 0.02% 769
2014
Q2 		$603K Sell
4,300
-1,129
-21% -$125K 0.02% 886
2014
Q1 		$603K Buy
5,429
+2,040
+60% +$222K 0.01% 854
2013
Q4 		$335K Buy
3,389
+94
+3% +$8.15K 0.04% 511
2013
Q3 		$250K Sell
3,295
-3,169
-49% -$206K 0.01% 1324
2013
Q2 		$361K Buy
+6,464
New +$382K 0.01% 1199

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PDT Partners's TARO Position: Q3 2021 in Review

PDT Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2021, closing a stake of 3,905 shares — an estimated $281K sold.

PDT Partners first reported a position in TARO in Q2 2013 and held it in 15 quarters. The position peaked at $2.66M in Q2 2015. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2021.

  • PDT Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2021 after selling out during the quarter.
  • PDT Partners sold 3,905 Taro Pharmaceutical Industries Ltd. shares in Q3 2021, an estimated $281K.
  • PDT Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 15 quarters.
  • PDT Partners's Taro Pharmaceutical Industries Ltd. position peaked at $2.66M in Q2 2015.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.